Lead exposure and plasma mRNA expression in ERBB2 gene

Area of Science:

• Environmental Health
• Molecular Biology
• Oncology

Background:

• Lead (Pb) exposure is epidemiologically linked to cancer, but evidence is inconsistent.
• ERBB2 receptor expression is implicated in human tumor development, proliferation, angiogenesis, and metastasis.
• Understanding the relationship between lead exposure and ERBB2 is crucial for cancer research.

Purpose of the Study:

• To investigate the association between blood lead levels and plasma mRNA expression of the ERBB2 gene in a healthy population.
• To provide further data on the potential link between environmental lead exposure and cancer-related gene expression.

Main Methods:

• Blood samples and health data were collected from 48 healthy men.
• Real-time polymerase chain reaction (PCR) was used to quantify ERBB2 gene expression.
• High-resolution inductively coupled mass spectrometry measured blood lead levels.

Main Results:

• A significant positive association was found between blood lead levels and ERBB2 mRNA expression (r²=0.5345; p<0.0001).
• The average blood lead level was 16.07±6.74 µg/dl, and ERBB2 mRNA expression was 6.44±3.07 ΔΔCt.

Conclusions:

• Blood lead levels are significantly associated with ERBB2 gene expression in healthy individuals.
• The molecular mechanisms underlying this association require further investigation through in vitro studies.
• This research contributes to understanding potential environmental risk factors in cancer development.